CBIS Latest News

Display # 
Cannabis Science Receives Delivery Notifications for First Greenhouse Orders as it Prepares Cannabinoid Observational and Clinical Studies Targeting Several Critical Ailments 08 Mar 2017
Cannabis Science Senior Executives to Co-Chair Special Session and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School 02 Mar 2017
Cannabis Science Announces Update on Proposed DPI Inhalation Device, CBD Infused Pain Patch, and Extends Praise for President Trump's Support of Medical Cannabis, Nationwide 24 Feb 2017
Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science's California and Nevada Property and Drug Development Projects 17 Feb 2017
Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada 08 Feb 2017
Cannabis Science Distributors Sells Out of Initial Test Batch of CBIS Metered Dose Inhalers (MDI), Notes Consumer High-Demand for the CBIS Inhaler in California 26 Jan 2017
Collaborative Research Agreement with Dana Farber Cancer Institute, Inc. 09 Jan 2017
Cannabis Science Inc. (CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce Joint Research and Drug Development Agreement; Collaborative Research Agreement 06 Jan 2017
Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada 21 Dec 2016
Harvard Director of Global Health Catalyst at the World-Renowned Dana Farber/Harvard Cancer Center States: Cannabis Science Presentation and Discussions a Great Success for Mutually Beneficial Partnership Opportunities with Harvard Medical School 21 Nov 2016